goto contents

Tuan Anh Le

The efficacy of concurrent chemoradiation for locally advanced non-small cell lung cancer prospectively treated at Cho Ray hospital, Vietnam, from 3/2009 to 3/2012

Universität Rostock, 2015

Abstract: From 1/3/2009 to 1/3/2012, 1158 patients were diagnosed of lung cancers at Cho Ray hospital, included adenocarcinoma (64.3%), squamous cell carcinoma (11.3%), small cell (4.9%) and others. In NSCLC, 38.4% were in stage III and 60 (14.2%)were selected to receive weekly Paclitaxel–Carboplatin concurrently with chest radiotherapy. Common severe toxicities included esophagitis (23.3%) and fatigue (23.3%). Response rate was 57.2%; median of overall and progression-free survival were 14.4 and 10.8 months. Pretreatment performance status and weight loss were two only significant prognostic factors.

doctoral thesis   free access    


OPACGVKDataCite Commons


all rights reserved

This work may only be used under the terms of the German Copyright Law (Urheberrechtsgesetz).